AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05430464 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 1726nm Laser System
Description: Subjects will receive 1726nm laser treatments on one side of the face
Study NCT05430464 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Laser System
Description: Subjects will receive sham laser treatments on the other side of the face.
Study NCT05632484 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cord blood sampling
Description: Collection of 2 milliliters (mL) of cord blood on an Ethylenediaminetetraacetic acid (EDTA) tube, on the day of delivery and after cutting the umbilical cord, for genetic testing
Study NCT05632484 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cord blood sampling
Description: Collection of 50 to 100 mL of cord blood from the cord blood collection bag
Study NCT05632484 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cord sampling
Description: Collection of 20 centimeters (cm) of umbilical cord
Study NCT04875260 — intervention group
Intervention type: OTHER
Intervention: Critical Care
Description: Critical care in the intensive care units
Study NCT06366893 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: DHA/AA emulsion supplement for preterm infant
Description: Enteral supplementation of DHA/AA emulsion
Study NCT05080660 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3526318
Description: Administered orally.
Study NCT05080660 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered orally.
Study NCT05752981 — intervention group
Intervention type: DEVICE
Intervention: multichannel time-resolved (tr) functional near infrared spectroscopy (fNIRS) (tr-fNIRS)
Description: Participants will be monitored during surgery using the multichannel time-resolved (tr) functional near infrared spectroscopy (fNIRS) (tr-fNIRS). This study is observational in nature and no intervention will be applied based on the results of the tr-fNIRS device.
Study NCT05683223 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group CBT for Social Anxiety Disorder
Description: Initial CBT will consist of 12 weekly, 2.5-hour group sessions. Later sessions (after session 7) become more individualized as the exposure practices are tailored to the individual participant's concerns. Most often, the exposures are completed outside the group environment. Session content includes various cognitive behavioral strategies tailored to SAD, such as psychoeducation, examining and challenging cognitive distortions, and exposure exercises.
Study NCT04970238 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levosimendan
Description: Test drug: drug preparation method: 5ml (12.5mg) levosimendan injection was mixed with 500ml 5% glucose injection, the initial loading dose was 6 µg / kg for 10 minutes, followed by continuous infusion of 0.1 µg/ kg / min for 24 hours.
Study NCT04970238 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Control drug: 5% glucose injection, intravenous injection method is the same as the experimental group pump dose, the initial load dose of treatment is 6 µg / kg for 10 minutes, followed by continuous infusion of 0.1 µg / kg / min for 24 hours.
Study NCT05683223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sertraline
Description: Non-responders will initiate sertraline at baseline (week 0) with 25 mg/day followed by a dose increase to 50 mg/day at week 1, 100 mg at week 4, 150 mg at week 6, and 200 mg at week 8. Upward dose titration may be slowed and the dose decreased if necessary due to side effects, but the clinician will attempt to titrate all symptomatic participants up to 200 mg/day if tolerated by week 8, with the last dose increase allowed at week 10. Participants will be assessed at each visit by the study psychiatrist for purposes of dose titration and monitoring. Symptomatic participants unable to reach 200 mg/day of sertraline due to side effects will be maintained in the trial if they are on at least 50 mg/day by week 8; all symptomatic participants will be titrated to their maximally tolerated dose (\< 200 mg/day sertraline). Any participant unable to tolerate sertraline will be discontinued and referred for clinical treatment.
Study NCT05683223 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individual CBT for Social Anxiety Disorder
Description: Participants who show no or only partial response to the initial group CBT will continue with an individual, tailored form of CBT plus adjunctive SSRI. The format of CBT will include
Study NCT05292131 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: bimekizumab
Description: Study participants will receive a single dose of bimekizumab (BKZ) administered subcutaneously in the Treatment Period.
Study NCT05292131 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bimekizumab
Description: Study participants will receive a single dose of bimekizumab (BKZ) administered subcutaneously in the Treatment Period.
Study NCT05254730 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: macro-micro tetrodes for intracranial recording
Description: novel design of tetrode micro electrodes within the standard macro intracranial electrodes used clinically for identification of the epileptogenic zone
Study NCT04872712 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Press needles
Description: Manual acupuncture using press needles
Study NCT04872712 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Filiform Needles
Description: Manual acupuncture using filiform needles
Study NCT00013026 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: CHF Self-management Education (Web-based Education)
Study NCT06466668 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Sleep study
Description: All subjects will undergo a polysomnography at home
Study NCT06466668 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: stress-related biomarkers and microbiome composition will be assessed using saliva samples
Description: stress and stress-related inflammatory biomarkers will be tested using saliva sample
Study NCT06466668 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Audiological tests
Description: Pure tone audiometry, Uncomfortable Loudness Levels, Distortion-Product Otoacoustic Emissions, tablet test for hyperacusis, tablet test for hearing screening
Study NCT05073081 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prehab for LSS
Description: The 8-week prehabilitation program will be delivered online by physiotherapists, chiropractors, and kinesiologists through synchronous and asynchronous exercise sessions, along with online educational sessions.
Study NCT05073081 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Participants in the control group will receive usual care as per surgeons' current practice.
Study NCT06003569 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BACK-S
Description: BACK = Better Asthma Control for Kids:~The BACK -Standard package includes a tailor-and-adapt to context strategy of approaches necessary to implement BACK in schools based on our past work, operationalized as an implementation blueprint to coordinate with partner roles of child/family, schools, healthcare teams and community resource agencies. This includes a facilitation strategy to support problem-solving through regular learning collaborative meetings for asthma navigators (bi-weekly), school nurses (monthly to bi-monthly) and health care champions (quarterly).
Study NCT06003569 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BACK-E
Description: The BACK-Enhanced package includes the BACK-Standard package plus an Enhanced strategy to develop interrelationships with students/family, schools, and community agencies providing resources to address social determinants of health.
Study NCT05235139 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IOL implantation experimental (ISOPURE 1.2.3.)
Description: Implantation of premium monofocal IOL ISOPURE 1.2.3.
Study NCT05235139 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: IOL implantation active comparator (Acrysof Vivity)
Description: Implantation of EDOF IOL Acrysof Vivity
Study NCT06087692 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Exercise
Description: -based game therapy applied in addition to aerobic exercise
Study NCT06640751 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health behavior intervention
Description: The program is a group-based intervention provided by a healthcare team consisting of researchers, cardiologists, family doctors, community healthcare workers, psychologists, and health education specialists. The intervention is structured around three modules-predisposing, enabling, and reinforcing factors-that provide a framework for educational interventions aimed at promoting healthy behaviors in hypertensive patients.
Study NCT06323668 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cardiac implantable electronic device extraction
Description: The CIED removal will be done as soon as possible within 7 days.
Study NCT04559360 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PRESTOapp
Description: The intervention group will be asked to use the app for a period of 2 months.
Study NCT05300633 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group-Based Community Reinforcement Approach and Family Training-Early Psychosis Intervention (CRAFT-EPI)
Description: Behavioral therapy adapted for families of young people experiencing early psychosis delivered via telemedicine to groups following an individual orientation. Group session topics include self-care, communication, functional analysis, positive reinforcement, treatment engagement, natural consequences, and problem solving. A happiness scale will be completed at each session. Will be provided in the context of an early psychosis intervention program that provides coordinated specialty care to 16- to 29-year-olds experiencing any diagnosis that can manifest as early psychosis.
Study NCT06339918 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: KegelExercise
Description: Kegel exercises (also called pelvic floor exercises)will be used to strengthen the pelvic floor muscles it will involve repeatedly contracting and relaxing the muscles that form part of the pelvic floor.
Study NCT06087146 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sauerkraut (Brassica oleracea v. capitata)
Description: The research material is a donation from the company Eko Bio Zrnje, Vrbovec, Croatia. It's grated pickle cabbage produced by fermentation in a saline solution (NaCl) in which the fermentation was stopped by pasteurization and was packed in glass 500g jars. The nutritional and microbiological composition was tested by the laboratories of the Faculty of Food and Biotechnology, as well as by the cultural laboratory approach confirmed the presence of bacteria that produce lactic acid (4.82·103 (±2.31) CFU/mL)
Study NCT06339918 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 4-7-8 breathing technique
Description: This can be performed in the following way: Participants taking part should locate a comfy spot to sit. Inhale to the count of 4. Hold their breath for 7 counts. To the count of 8, release air via their mouth.
Study NCT06339918 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 4-7-8 breathing technique
Description: This can be performed in the following way: Participants taking part should locate a comfy spot to sit. Inhale to the count of 4. Hold their breath for 7 counts. To the count of 8, release air via their mouth.
Study NCT06283238 — intervention group
Intervention type: DRUG
Intervention: Immune checkpoint inhibitor (ICI) or chemotherapy alone
Description: Immune checkpoint inhibitor (i.e. pembrolizumab, nivolumab, or another checkpoint inhibitor) or chemotherapy alone
Study NCT05075382 — intervention group
Intervention type: PROCEDURE
Intervention: Elbow surgery for fracture
Description: This group will undergo a surgery in order to fix a broken elbow.
Study NCT04607252 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin plus Megestrol acetate
Description: metformin 1500mg, per day, oral; megestrol acetate 160mg per day, oral
Study NCT04607252 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Megestrol Acetate
Description: megestrol acetate 160mg per day, oral
Study NCT04545502 — intervention group
Intervention type: DEVICE
Intervention: Gelsoft Plus Vascular Graft
Description: Gelatin coated, knitted vascular prosthesis implanted to act as a conduit for channeling blood during repair of damaged or diseased vessels.
Study NCT04545502 — intervention group
Intervention type: DEVICE
Intervention: Vascular Bypass Graft
Description: Gelatin coated, knitted vascular prosthesis implanted to act as an extra-anatomical bypass for channeling blood during repair of damaged or diseased vessels.
Study NCT04545502 — intervention group
Intervention type: DEVICE
Intervention: Cardiovascular Patch
Description: Cardiovascular knitted polyester patches are frequently used to treat the carotid or femoral arteries to prevent stroke and repair damage to vessels.
Study NCT04545502 — intervention group
Intervention type: DEVICE
Intervention: Gelweave Vascular Graft
Description: The Gelweave woven polyester vascular graft allows replacement of large sections of arteries and, following anastomosis to the native blood vessel, provides a stable conduit for blood flow.
Study NCT04545502 — intervention group
Intervention type: DEVICE
Intervention: Gelweave Valsalva Vascular Graft
Description: This woven polyester graft is designed to match the aortic root anatomy and is implanted to repair or replace a portion of the aorta in case of an aneurysm, dissection or coarctation at the level of the thoracic aorta.
Study NCT04842968 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Methylene blue injection
Description: Methylene blue solution is injected ex vivo in the main supplying artery trunk of the freshly removed colorectal specimen. (50 mg in 30 ml saline)
Study NCT05568719 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Testing of hepatic AAV Vector integration
Description: Evaluation of AAV vector integration in participants for whom a sample of liver has been obtained through biopsy or surgical resection when clinically indicated
Study NCT06066424 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rimiducid
Description: Given by (IV) vein
Study NCT06066424 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TROP2-CAR-NK Cells
Description: Given by (IV) vein
Study NCT06643533 — intervention group
Intervention type: OTHER
Intervention: Fecal Microbiota Transplantation
Description: The FMT capsules will be prepared by matching the gut microbiome profiles of healthy donors with those of patients who achieved a complete response to the triple therapy. The FMT capsules will be taken orally at a dosage of 30 capsules per day for the first 3 days of each treatment cycle. The FMT intervention will be administered in 6 cycles, with each cycle lasting for 21 days (Q3W). The duration of the treatment will be determined by the response to therapy, with a maximum of 6 cycles or until disease progression, intolerable toxicity, or participant withdrawal of consent. The FMT capsules are intended to modify the gut microbiome to reverse the resistance to the triple therapy and enhance the therapeutic response.
Study NCT04878471 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pudexacianinium chloride
Description: Intravenous
Study NCT04878471 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intravenous
Study NCT06373718 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cognitive Behavioral Therapy for Insomnia
Description: CBT-I improves sleep through a combination of behavioral interventions (stimulus control (SC), sleep restriction (SR)), cognitive therapy (CT) as well as additional components such as mindfulness training and sleep hygiene education. SC is an intervention that re-establishes the connection between the bed/bedroom with sleep to help develop a more consistent sleep/wake pattern. SR leads to higher quality sleep by reducing excessive time spent in bed to the actual amount of sleep, thereby creating mild sleep deprivation and increasing the homeostatic sleep drive. Like CT for other disorders, CT for insomnia targets maladaptive thoughts and cognitions that may interfere with sleep.
Study NCT04526080 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TheraBionic Device
Description: Amplitude-modulated electromagnetic fields will be self-administered and given continuously to patients in three courses of 60-minute treatments per day, administered in the morning, at noon and in the evening at the patient's home, with the exception of the first 60-minute treatment, which will be delivered at the research site. Each 6-week treatment period will be considered a cycle of treatment. For subjects who are randomized to the active arm, the device will be programmed with hepatocellular carcinoma-specific modulation frequencies and will be activated for more than 200 one-hour treatment sessions.
Study NCT04526080 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Device
Description: Subjects who are randomized to receive placebo, will receive the same instructions and a similar device. The placebo device will look and sound the same as the active device, but will not deliver the modulation frequencies. For subjects randomized to the placebo arm, the device will not emit any hepatocellular carcinoma-modulation frequencies and will be activated for more than 200 one-hour treatment sessions.
Study NCT05456451 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: noninvasive vagus nerve srimulation
Description: Non-invasive Vagus nerve stimulation (VNS) stimulates the vagus nerve through the ear via a headset. VNS is a non-pharmacological intervention with the potential to improve walking, cognition, fatigue, and autonomic functions in the treatment of Parkinson's disease.
Study NCT04960761 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: İntervention Group
Description: In the experimental group, pre-operative anxiety and quality of life scales will be applied to the child and their parents before and after the operation with audio and picture books, the preoperative quality of life scale will be made, the postoperative anxiety and quality of life scale will be repeated and the early mobilization scale will be made.~The control group will be routinely informed before the operation, an anxiety scale will be given to the child and their parents before the operation, a quality of life scale will be given to the child, the postoperative anxiety and quality of life scale will be repeated, and early mobilization form will be applied.
Study NCT05489211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Datopotamab deruxtecan (Dato-DXd)
Description: Intravenous (IV) Antibody drug conjugate
Study NCT05489211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Administered orally
Study NCT05489211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil
Description: Administered as an IV
Study NCT05489211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Volrustomig
Description: Administered as an IV
Study NCT05489211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Administered as an IV
Study NCT05489211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin LV
Description: Administered as an IV
Study NCT05489211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Administered as an IV
Study NCT05489211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rilvegostomig
Description: Administered as an IV
Study NCT05489211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone/ prednisolone
Description: Administered orally
Study NCT05489211 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Administered as an IV
Study NCT04846881 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iclepertin
Description: Iclepertin
Study NCT04846881 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06387719 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Magnetic resonance imaging
Description: * Basic sequence for ethical consideration: evaluation of casual findings.~* Structural MRI.~* Functional MRI (fMRI) in the Resting-state~* fMRI- task based. Presented in a computer screen on a magnetically compatible googles.
Study NCT06066424 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine phosphate
Description: Given by (IV) vein
Study NCT06373718 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia
Description: CBT-I improves sleep through a combination of behavioral interventions (stimulus control (SC), sleep restriction (SR)), cognitive therapy (CT) as well as additional components such as mindfulness training and sleep hygiene education. SC is an intervention that re-establishes the connection between the bed/bedroom with sleep to help develop a more consistent sleep/wake pattern. SR leads to higher quality sleep by reducing excessive time spent in bed to the actual amount of sleep, thereby creating mild sleep deprivation and increasing the homeostatic sleep drive. Like CT for other disorders, CT for insomnia targets maladaptive thoughts and cognitions that may interfere with sleep.
Study NCT06066424 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given by (IV) vein
Study NCT06527872 — intervention group
Intervention type: OTHER
Intervention: None (Observational study)
Description: Not Applicable since Observational Study
Study NCT06233630 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Control Test - spinal anesthesia
Description: No peripheral nerve block Only spinal anesthesia
Study NCT06233630 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine 0.2% Injectable Solution ESPB
Description: ultrasound guided erector spinae plane block (ESPB) - L2 level, unilateral